USC, UCLA among clinical trial team behind Leqembi, the first Alzheimer’s to get full FDA approval

For more than a century there was no treatment for the debilitating disease, but now more than 6 million Americans with Alzheimer's have some hope for a better future. Joy Benedict reports.